Sara De Grazia

459 total citations
17 papers, 382 citations indexed

About

Sara De Grazia is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Sara De Grazia has authored 17 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Sara De Grazia's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Biochemical and Molecular Research (3 papers). Sara De Grazia is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Biochemical and Molecular Research (3 papers). Sara De Grazia collaborates with scholars based in Italy, Belgium and United Kingdom. Sara De Grazia's co-authors include Vittorio Unfer, Laura De Luca, Alba Chimirri, Stefania Ferro, Hiroshi Matsubara, David J. Procter, Karl D. Collins, Zeger Debyser, Frauke Christ and Gianfranco Carlomagno and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Sara De Grazia

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara De Grazia Italy 12 173 106 97 87 48 17 382
Robert F. Kaltenbach United States 14 357 2.1× 80 0.8× 206 2.1× 53 0.6× 14 0.3× 22 713
Naoki Miyakoshi Japan 14 312 1.8× 39 0.4× 98 1.0× 22 0.3× 56 1.2× 17 503
James Hand United States 12 70 0.4× 70 0.7× 156 1.6× 68 0.8× 21 0.4× 32 495
Kevin M. Peese United States 9 232 1.3× 41 0.4× 295 3.0× 27 0.3× 6 0.1× 13 523
István Káldor United States 11 219 1.3× 111 1.0× 123 1.3× 72 0.8× 19 0.4× 21 482
Charlotte Møller Denmark 10 27 0.2× 14 0.1× 107 1.1× 25 0.3× 5 0.1× 18 334
Jacob J. Plattner United States 10 171 1.0× 68 0.6× 173 1.8× 20 0.2× 4 0.1× 11 347
Karishma Patel Australia 10 75 0.4× 62 0.6× 250 2.6× 15 0.2× 5 0.1× 24 512
Robert L. Rosati United States 10 137 0.8× 15 0.1× 176 1.8× 7 0.1× 9 0.2× 18 395
Namkyu Lee South Korea 13 340 2.0× 40 0.4× 193 2.0× 11 0.1× 9 0.2× 25 517

Countries citing papers authored by Sara De Grazia

Since Specialization
Citations

This map shows the geographic impact of Sara De Grazia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara De Grazia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara De Grazia more than expected).

Fields of papers citing papers by Sara De Grazia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara De Grazia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara De Grazia. The network helps show where Sara De Grazia may publish in the future.

Co-authorship network of co-authors of Sara De Grazia

This figure shows the co-authorship network connecting the top 25 collaborators of Sara De Grazia. A scholar is included among the top collaborators of Sara De Grazia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara De Grazia. Sara De Grazia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Micheletto, Claudio, Giulia Lorenzini, Sara De Grazia, et al.. (2025). Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey. Human Vaccines & Immunotherapeutics. 21(1). 2552557–2552557.
2.
Monastra, Giovanni, et al.. (2016). Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage. Expert Opinion on Drug Delivery. 13(12). 1695–1708. 42 indexed citations
3.
Costantino, D, et al.. (2014). Peripheral neuropathy in obstetrics: efficacy and safety of α-lipoic acid supplementation.. PubMed. 18(18). 2766–71. 25 indexed citations
4.
Grazia, Sara De, Gianfranco Carlomagno, Vittorio Unfer, & Pietro Cavalli. (2012). Myo-inositol soft gel capsules may prevent the risk of coffee-induced neural tube defects. Expert Opinion on Drug Delivery. 9(9). 1033–1039. 18 indexed citations
5.
Carlomagno, Gianfranco, Sara De Grazia, Vittorio Unfer, & Fedele Manna. (2012). Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use. Expert Opinion on Drug Delivery. 9(3). 267–271. 31 indexed citations
6.
Gitto, Rosaria, Laura De Luca, Sara De Grazia, & Alba Chimirri. (2012). Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants. Current Topics in Medicinal Chemistry. 12(9). 971–993. 11 indexed citations
7.
Luca, Laura De, Stefania Ferro, Francesca Morreale, Sara De Grazia, & Alba Chimirri. (2011). Inhibitors of the Interactions between HIV‐1 IN and the Cofactor LEDGF/p75. ChemMedChem. 6(7). 1184–1191. 32 indexed citations
8.
Luca, Laura De, Rosaria Gitto, Frauke Christ, et al.. (2011). 4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. Antiviral Research. 92(1). 102–107. 19 indexed citations
9.
Ferro, Stefania, Sara De Grazia, Laura De Luca, et al.. (2011). Microwave Assisted Organic Synthesis (MAOS) of Small Molecules as Potential HIV-1 Integrase Inhibitors. Molecules. 16(8). 6858–6870. 6 indexed citations
10.
Brancatelli, Giovanna, et al.. (2011). 3-[2-(1H-1,3-Benzodiazol-2-yl)ethyl]-1,3-oxazolidin-2-one. Acta Crystallographica Section E Structure Reports Online. 67(5). o1083–o1083. 1 indexed citations
11.
Collins, Karl D., Brice Sautier, Sara De Grazia, et al.. (2010). Selective Reductions of Cyclic 1,3‐Diesters by Using SmI2 and H2O. Chemistry - A European Journal. 16(33). 10240–10249. 42 indexed citations
12.
Ferro, Stefania, Laura De Luca, Maria Letizia Barreca, et al.. (2010). New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action. Bioorganic & Medicinal Chemistry. 18(15). 5510–5518. 15 indexed citations
13.
Luca, Laura De, Sara De Grazia, Stefania Ferro, et al.. (2010). HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation. European Journal of Medicinal Chemistry. 46(2). 756–764. 32 indexed citations
14.
Gitto, Rosaria, Laura De Luca, Stefania Ferro, et al.. (2009). N‐substituted isoquinoline derivatives as potential AChE inhibitors. Journal of Heterocyclic Chemistry. 47(1). 54–62. 4 indexed citations
15.
Ferro, Stefania, Sara De Grazia, Laura De Luca, et al.. (2009). Structural Modification of Diketo Acid Portion in 1H-Benzylindole Derivatives HIV-1 Integrase Inhibitors. Heterocycles. 78(4). 947–947. 7 indexed citations
16.
Grazia, Sara De, et al.. (2009). Selective Reductions of Cyclic 1,3-Diesters Using SmI2 and H2O. Journal of the American Chemical Society. 131(21). 7214–7215. 66 indexed citations
17.
Ferro, Stefania, Laura De Luca, Maria Letizia Barreca, et al.. (2008). Docking Studies on a New Human Immodeficiency Virus Integrase−Mg−DNA Complex: Phenyl Ring Exploration and Synthesis of 1H-Benzylindole Derivatives through Fluorine Substitutions. Journal of Medicinal Chemistry. 52(2). 569–573. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026